Toxovax®
Toxovax is an injectable live vaccine used in susceptible breeding female sheep to stimulate active immunity against Toxoplasma gondii, a ubiquitous parasite acquired from the environment, and a common cause of barrenness and abortion.
Presentation
Concentrate and diluent for suspension for injection.
Concentrate: cloudy suspension. Diluent: colourless solution.
Active ingredients
Live, concentrated vaccine containing ≥ 105 tachyzoites of the S48 strain of Toxoplasma gondii per dose. Unisolve® is supplied as a diluent for dilution prior to use.
Target species
Sheep
Indications for use
Toxovax is a live vaccine for the active immunisation of susceptible breeding female sheep to reduce the effects of infection by Toxoplasma gondii, namely early embryonic death, barrenness and abortion.
A single 2 ml, intramuscular injection is given at least 3 weeks prior to mating.
Vaccination with Toxovax is known to protect for at least two lambing seasons. Toxovax can be given concurrently with Enzovax®.
Withdrawal periods
Sheep - meat 42 days
Packaging
Carton with 1 vial of vaccine, 1 vial of Unisolve and one transfer spike. Vials containing 20 or 50 doses supplied together with Unisolve. An administration kit including a vented transfer device for vaccine reconstitution and disposable automatic syringe with a Sterimatic needle protection and cleaning needle system is available.
Legal category
POM-V
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018
